MAPT and Alzheimer disease: The “GSK3 hypothesis of AD” [68] proposed that the overactivation of GSK3β accounts for several features of this pathology such as memory impairment, tau phosphorylation, increased amyloid production, microglia-mediated inflammation, and neuronal death.